| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| pcsk9 inhibitors cardiovascular outcomes | 0.92 | 0.2 | 8234 | 28 | 40 |
| pcsk9 | 0.73 | 0.4 | 4035 | 23 | 5 |
| inhibitors | 0.93 | 0.6 | 7968 | 83 | 10 |
| cardiovascular | 0.54 | 0.2 | 9465 | 93 | 14 |
| outcomes | 0.29 | 0.9 | 1112 | 37 | 8 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| pcsk9 inhibitors cardiovascular outcomes | 0.77 | 0.8 | 5952 | 21 |
| pcsk9 inhibitors and mortality benefit | 1.19 | 0.9 | 7896 | 62 |
| pcsk9 inhibitors patient information | 0.64 | 0.6 | 9980 | 4 |
| what is the downside of pcsk9 inhibitors | 1.54 | 1 | 2378 | 37 |
| pcsk9 inhibitors for cholesterol reduction | 1 | 0.8 | 73 | 95 |
| pcsk9 inhibitors clinical trials | 1.95 | 0.6 | 9797 | 79 |
| pcsk9 inhibitors and diabetes | 0.16 | 0.6 | 4494 | 1 |
| pcsk9 inhibitors and lipoprotein a | 0.54 | 0.1 | 7916 | 50 |
| pcsk9 inhibitors side effects discussion | 0.94 | 0.9 | 9041 | 93 |
| pcsk9 inhibitors mechanism of action | 0.36 | 1 | 9433 | 58 |
| adverse effects of pcsk9 inhibitors | 1.72 | 0.1 | 1017 | 76 |
| pcsk9 inhibitors and liver disease | 0.64 | 1 | 1968 | 29 |
| pcsk9 inhibitors stroke prevention | 1.61 | 1 | 3306 | 20 |
| mechanism of pcsk9 inhibitors | 1.03 | 0.8 | 197 | 60 |
| dangers of pcsk9 inhibitors | 0.14 | 0.2 | 4429 | 35 |
| side effects pcsk9 inhibitors | 1.12 | 0.7 | 9489 | 89 |
| cholesterol medication pcsk9 inhibitor | 0.16 | 0.1 | 330 | 51 |
| pcsk 9 inhibitors uk patient informaion | 1.72 | 0.1 | 8057 | 17 |
| pcsk9 inhibitor effect on triglycerides | 0.71 | 1 | 6984 | 94 |
| what is pcsk9 inhibitor therapy | 0.24 | 1 | 8129 | 65 |
